Cargando…
Emerging Antibacterial Strategies with Application of Targeting Drug Delivery System and Combined Treatment
At present, some bacteria have developed significant resistance to almost all available antibiotics. One of the reasons that cannot be ignored is long-term exposure of bacteria to the sub-minimum inhibitory concentration (MIC) of antibiotics. Therefore, it is necessary to develop a targeted antibiot...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423451/ https://www.ncbi.nlm.nih.gov/pubmed/34511911 http://dx.doi.org/10.2147/IJN.S311248 |
_version_ | 1783749467999043584 |
---|---|
author | Zhang, Wenli Hu, Enshi Wang, Yajie Miao, Si Liu, Yanyan Hu, Yumin Liu, Ji Xu, Bohui Chen, Daquan Shen, Yan |
author_facet | Zhang, Wenli Hu, Enshi Wang, Yajie Miao, Si Liu, Yanyan Hu, Yumin Liu, Ji Xu, Bohui Chen, Daquan Shen, Yan |
author_sort | Zhang, Wenli |
collection | PubMed |
description | At present, some bacteria have developed significant resistance to almost all available antibiotics. One of the reasons that cannot be ignored is long-term exposure of bacteria to the sub-minimum inhibitory concentration (MIC) of antibiotics. Therefore, it is necessary to develop a targeted antibiotic delivery system to improve drug delivery behavior, in order to delay the generation of bacterial drug resistance. In recent years, with the continuous development of nanotechnology, various types of nanocarriers that respond to the infection microenvironment, targeting specific bacterial targets, and targeting infected cells, and so on, are gradually being used in the delivery of antibacterial agents to increase the concentration of drugs at the site of infection and reduce the side effects of drugs in normal tissues. Here, this article describes in detail the latest research progress on nanocarriers for antimicrobial, and commonly used targeted antimicrobial strategies. The advantages of the combination of nanotechnology and targeting strategies in combating bacterial infections are highlighted in this review, and the upcoming opportunities and remaining challenges in this field are rationally prospected. |
format | Online Article Text |
id | pubmed-8423451 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-84234512021-09-09 Emerging Antibacterial Strategies with Application of Targeting Drug Delivery System and Combined Treatment Zhang, Wenli Hu, Enshi Wang, Yajie Miao, Si Liu, Yanyan Hu, Yumin Liu, Ji Xu, Bohui Chen, Daquan Shen, Yan Int J Nanomedicine Review At present, some bacteria have developed significant resistance to almost all available antibiotics. One of the reasons that cannot be ignored is long-term exposure of bacteria to the sub-minimum inhibitory concentration (MIC) of antibiotics. Therefore, it is necessary to develop a targeted antibiotic delivery system to improve drug delivery behavior, in order to delay the generation of bacterial drug resistance. In recent years, with the continuous development of nanotechnology, various types of nanocarriers that respond to the infection microenvironment, targeting specific bacterial targets, and targeting infected cells, and so on, are gradually being used in the delivery of antibacterial agents to increase the concentration of drugs at the site of infection and reduce the side effects of drugs in normal tissues. Here, this article describes in detail the latest research progress on nanocarriers for antimicrobial, and commonly used targeted antimicrobial strategies. The advantages of the combination of nanotechnology and targeting strategies in combating bacterial infections are highlighted in this review, and the upcoming opportunities and remaining challenges in this field are rationally prospected. Dove 2021-09-03 /pmc/articles/PMC8423451/ /pubmed/34511911 http://dx.doi.org/10.2147/IJN.S311248 Text en © 2021 Zhang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Zhang, Wenli Hu, Enshi Wang, Yajie Miao, Si Liu, Yanyan Hu, Yumin Liu, Ji Xu, Bohui Chen, Daquan Shen, Yan Emerging Antibacterial Strategies with Application of Targeting Drug Delivery System and Combined Treatment |
title | Emerging Antibacterial Strategies with Application of Targeting Drug Delivery System and Combined Treatment |
title_full | Emerging Antibacterial Strategies with Application of Targeting Drug Delivery System and Combined Treatment |
title_fullStr | Emerging Antibacterial Strategies with Application of Targeting Drug Delivery System and Combined Treatment |
title_full_unstemmed | Emerging Antibacterial Strategies with Application of Targeting Drug Delivery System and Combined Treatment |
title_short | Emerging Antibacterial Strategies with Application of Targeting Drug Delivery System and Combined Treatment |
title_sort | emerging antibacterial strategies with application of targeting drug delivery system and combined treatment |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423451/ https://www.ncbi.nlm.nih.gov/pubmed/34511911 http://dx.doi.org/10.2147/IJN.S311248 |
work_keys_str_mv | AT zhangwenli emergingantibacterialstrategieswithapplicationoftargetingdrugdeliverysystemandcombinedtreatment AT huenshi emergingantibacterialstrategieswithapplicationoftargetingdrugdeliverysystemandcombinedtreatment AT wangyajie emergingantibacterialstrategieswithapplicationoftargetingdrugdeliverysystemandcombinedtreatment AT miaosi emergingantibacterialstrategieswithapplicationoftargetingdrugdeliverysystemandcombinedtreatment AT liuyanyan emergingantibacterialstrategieswithapplicationoftargetingdrugdeliverysystemandcombinedtreatment AT huyumin emergingantibacterialstrategieswithapplicationoftargetingdrugdeliverysystemandcombinedtreatment AT liuji emergingantibacterialstrategieswithapplicationoftargetingdrugdeliverysystemandcombinedtreatment AT xubohui emergingantibacterialstrategieswithapplicationoftargetingdrugdeliverysystemandcombinedtreatment AT chendaquan emergingantibacterialstrategieswithapplicationoftargetingdrugdeliverysystemandcombinedtreatment AT shenyan emergingantibacterialstrategieswithapplicationoftargetingdrugdeliverysystemandcombinedtreatment |